About Molecule 77
Overview of our company; staff biographies
Our Team
Mission Statement
We seek to break down walls of traditional development and implementation of our therapies, as quantified through science data and traceability, and to show users globally the benefits of using M77 products.
Executive Team
Anthony Rushford
President, Chief Scientist
John P. Wick
Vice-president, Managing Director
Business Plan
Opportunity
Estimated potential market size: $200 billion annually worldwide.
We invite inquiries from potential partners who understand the need and share our vision.
Our first round may include stock with variable ownership. Our first partner will have first right to purchase any additional shares when offered through any subsidiary company.
Other opportunities may include national or regional distributorships and white-label branding.
Application of Funds
- Acquire equipment to filter and sterilize M77 vials at production scale/volume.
- Additional funding for clinical studies and patent.
Contact us!